Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROIKA-1: PK Similarity of HD201 to Herceptin in Healthy Males
NCT03776240Phase 1Completed
- Sponsor
- Prestige Biopharma Limited
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of coprelotamab in breast cancer (3 arms), sponsored by Prestige Biopharma Limited. Started Apr 2019; status: completed.
02
Drugs
coprelotamab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03776240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03776240.